Profil
Anders Dyhr Dombernowsky-Toft currently works at Aptol Pharma ApS, as Executive Chairman from 2023.
Dr. Dombernowsky-Toft also formerly worked at Cessatech A, as Director from 2024 to 2025, IMP Scandinavia ApS, as Director from 2024 to 2025, and SynAct Pharma AB, as Chief Medical Officer from 2021 to 2022.
Dr. Dombernowsky-Toft received his doctorate degree from the University of Copenhagen, Masters Business Admin degree in 2014 from International Institute for Management Development, and doctorate degree from Copenhagen University Hospital.
Postes actifs de Anders Dyhr Toft
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Anders Dyhr Toft
| Sociétés | Poste | Fin |
|---|---|---|
| CESSATECH A/S | Directeur/Membre du Conseil | 01/03/2025 |
| SYNACT PHARMA AB | Directeur Technique/Scientifique/R&D | 01/02/2022 |
Formation de Anders Dyhr Toft
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Copenhagen University Hospital
Copenhagen University Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SynAct Pharma AB
SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
Cessatech A/S
Cessatech A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for children for the treatment of pediatric acute pain | Health Technology |
















